Yanling Feng Selected Research

Ovarian Epithelial Carcinoma

1/2021	The impact of lymph node dissection on survival in patients with clinical early-stage ovarian cancer.
1/2021	Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial.
9/2020	Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept.
1/2019	Retrospective analysis of the efficacy of adjuvant CIK cell therapy in epithelial ovarian cancer patients who received postoperative chemotherapy.
1/2015	GOLPH3L is a Novel Prognostic Biomarker for Epithelial Ovarian Cancer.
1/2012	Screening and identification of biomarkers in ascites related to intrinsic chemoresistance of serous epithelial ovarian cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanling Feng Research Topics

Disease

35	Neoplasms (Cancer) 11/2023 - 01/2012
18	Infections 08/2023 - 10/2012
15	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 01/2015
8	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2024 - 04/2015
8	Inflammation (Inflammations) 02/2024 - 01/2015
7	Pneumonia (Pneumonitis) 02/2024 - 09/2016
7	Chronic Hepatitis B 01/2022 - 11/2015
6	Ovarian Epithelial Carcinoma 01/2021 - 01/2012
5	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2015
4	Non-alcoholic Fatty Liver Disease 05/2023 - 01/2023
4	Carcinoma (Carcinomatosis) 01/2023 - 04/2015
4	Disease Progression 12/2022 - 01/2020
4	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2015
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 05/2010
3	Colorectal Neoplasms (Colorectal Cancer) 09/2022 - 01/2015
3	HIV Infections (HIV Infection) 09/2022 - 01/2017
3	Carcinogenesis 01/2022 - 01/2021
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2019
3	Hepatitis 01/2022 - 09/2021
3	Colonic Neoplasms (Colon Cancer) 01/2022 - 03/2018
3	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2018
3	Liver Diseases (Liver Disease) 09/2021 - 01/2011
3	Fibrosis (Cirrhosis) 05/2021 - 01/2020
2	COVID-19 01/2023 - 01/2020
2	Dysbiosis 01/2023 - 01/2023
2	Acquired Immunodeficiency Syndrome (AIDS) 09/2022 - 01/2018
2	Colitis 01/2022 - 01/2017
2	Ascites 01/2021 - 01/2012
2	Neoplasm Metastasis (Metastasis) 06/2020 - 03/2018
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 01/2016
2	Endometrial Neoplasms (Endometrial Cancer) 12/2014 - 04/2013
1	Communicable Diseases (Infectious Diseases) 12/2024
1	Bone Resorption 03/2024
1	Osteoporosis 03/2024
1	Ataxia Telangiectasia (Louis Bar Syndrome) 02/2024
1	Acute Kidney Injury (Acute Renal Failure) 12/2023
1	Alzheimer Disease (Alzheimer's Disease) 10/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2023
1	Atherosclerosis 09/2023
1	Sepsis (Septicemia) 06/2023

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 03/2024 - 05/2010
15	Biomarkers (Surrogate Marker)IBA 01/2024 - 05/2010
8	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2020
6	PlatinumIBA 12/2022 - 10/2017
5	MicroRNAs (MicroRNA)IBA 09/2023 - 01/2017
5	Anti-Bacterial Agents (Antibiotics)IBA 08/2023 - 09/2016
5	Messenger RNA (mRNA)IBA 09/2022 - 01/2015
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 08/2018
4	CytokinesIBA 01/2023 - 01/2012
4	RNA (Ribonucleic Acid)IBA 09/2022 - 01/2015
4	AntigensIBA 01/2022 - 03/2013
4	CollagenIBA 09/2021 - 03/2012
3	Virulence Factors (Pathogenicity Factors)IBA 06/2023 - 08/2021
3	Ethanol (Ethyl Alcohol)IBA 05/2023 - 01/2011
3	LipidsIBA 01/2023 - 02/2012
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2018
3	niraparibIBA 12/2022 - 01/2020
3	Hepatitis B e AntigensIBA 01/2022 - 12/2020
3	Circular RNAIBA 11/2020 - 01/2020
3	ProteomeIBA 06/2012 - 05/2010
2	16S Ribosomal RNAIBA 12/2024 - 01/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 02/2024
2	Carboplatin (JM8)FDA LinkGeneric 03/2024 - 04/2013
2	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 12/2023
2	Phosphotransferases (Kinase)IBA 02/2024 - 01/2020
2	LipopolysaccharidesIBA 02/2024 - 09/2022
2	Amyloid (Amyloid Fibrils)IBA 10/2023 - 12/2022
2	oxidized low density lipoproteinIBA 09/2023 - 02/2012
2	Adenosine Triphosphate (ATP)IBA 01/2023 - 03/2018
2	Sirtuin 2IBA 12/2022 - 01/2021
2	Oxygen (Dioxygen)IBA 01/2022 - 01/2018
2	NAD (NADH)IBA 01/2022 - 01/2021
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 11/2021 - 01/2020
2	Sirtuin 1IBA 01/2021 - 01/2020
2	Nucleic AcidsIBA 12/2020 - 03/2016
2	Competitive Endogenous RNAIBA 10/2020 - 01/2020
2	C-Reactive ProteinIBA 01/2020 - 02/2012
2	AlbuminsIBA 01/2020 - 01/2015
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2019 - 10/2017
2	Interleukin-13IBA 01/2017 - 10/2015
2	Matrix Metalloproteinases (MMPs)IBA 01/2015 - 03/2012
1	puerarinIBA 03/2024
1	Monoclonal AntibodiesIBA 03/2024
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2024
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 12/2023
1	Dichlorodiphenyldichloroethane (DDD)IBA 11/2023
1	HMGB1 Protein (HMG1)IBA 09/2023
1	capsular-polysaccharide galactohydrolaseIBA 08/2023

Therapy/Procedure

15	Therapeutics 02/2024 - 06/2014
9	Drug Therapy (Chemotherapy) 03/2024 - 01/2012
5	Neoadjuvant Therapy 01/2021 - 10/2016
3	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 06/2020
3	Hysterectomy 01/2023 - 04/2015
3	Cytoreduction Surgical Procedures 01/2022 - 01/2015
2	Immunotherapy 12/2023 - 01/2019
2	Lasers (Laser) 08/2023 - 01/2012
2	Radiotherapy 01/2023 - 04/2013
2	Phage Therapy 01/2023 - 10/2022
2	Adjuvant Chemotherapy 12/2014 - 04/2013
1	TP protocol 03/2024